We are dedicated to making quality medication affordable globally. We focus on expanding one of our main portfolio, oncology, using advanced R&D to develop medicines for highly regulated markets and broadening our global impact.
Novugen enhances in achieving the desired quality of our products with advanced R&D and systematic Quality by Design (QbD) approach.
Prostate cancer Breast cancer Lung Cancer Blood cancer Renal cancer Colorectal cancer Ovarian & Uterine cancer Cervical cancer Thyroid cancer Liver cancer Pancreatic cancer Gastrointestinal stromal tumours (GIST) Immunosuppressants (Rheumatology & Organ Transplants) 
Our oncology plant is strategically located near the Kuala Lumpur International Airport at Enstek Park, Malaysia and holds unique features:
Built as a multiproduct commercial manufacturing facility to conduct commercial cGMP manufacturing of APIs for both clinical trial supplies and commercial products for global markets. The facility is designed for phase-wise expansion to meet global demand of oncology APIs.
